Original Research
Published on 14 Dec 2022
The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload
in Hypertension

- 4,453 views
- 5 citations
Original Research
Published on 14 Dec 2022
in Hypertension
Original Research
Published on 07 Dec 2022
in Hypertension
Correction
Published on 05 Dec 2022
in Hypertension
Original Research
Published on 05 Dec 2022
in Hypertension
Original Research
Published on 01 Dec 2022
in Hypertension
Original Research
Published on 23 Nov 2022
in Hypertension
Review
Published on 23 Nov 2022
in Hypertension
Original Research
Published on 23 Nov 2022
in Hypertension
Systematic Review
Published on 21 Nov 2022
in Hypertension
Systematic Review
Published on 17 Nov 2022
in Hypertension
Review
Published on 15 Nov 2022
in Hypertension
Original Research
Published on 15 Nov 2022
in Hypertension
Original Research
Published on 15 Nov 2022
in Hypertension
Original Research
Published on 14 Nov 2022
in Hypertension
Original Research
Published on 10 Nov 2022
in Hypertension
Original Research
Published on 10 Nov 2022
in Hypertension